Role of the adjacent stroma cells in prostate cancer development and progression: Synergy between TGF-β and IGF signaling

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Lee, Chung ^a,b,c,d   Jia, Zhenyu ^c,e,f   Rahmatpanah, Farah ^c   Zhang, Qiang ^a   Zi, Xiaolin ^b   McClelland, Michael ^c   Mercola, Dan ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^e UNIVERSITY OF AKRON   (United States)

^f Northeast Ohio Medical University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANDROGEN RECEPTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN; ANDROGEN; ESTROGEN; ESTROGEN RECEPTOR; SOMATOMEDIN;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER PREVENTION; CARCINOGENESIS; CELL INTERACTION; CELL PROLIFERATION; EMBRYO DEVELOPMENT; EPITHELIUM CELL; ESTROGEN ACTIVITY; FIBROBLAST; GLEASON SCORE; HOMEOSTASIS; HUMAN; MALIGNANT TRANSFORMATION; MYOFIBROBLAST; PRIMITIVE STREAK; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STROMA CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; UROGENITAL SINUS; ANIMAL; CYTOLOGY; DISEASE COURSE; MALE; METABOLISM; MOUSE; PROSTATE; PROSTATE TUMOR;

ANDROGENS; ANIMALS; DISEASE PROGRESSION; EPITHELIAL CELLS; ESTROGENS; HUMANS; MALE; MICE; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; SOMATOMEDINS; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84904187772     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/502093     Document Type: Review

References (87)

1. Fearon E. R., Vogelstein B., A genetic model for colorectal tumorigenesis. Cell 1990 61 5 759 767 2-s2.0-0025312728 10.1016/0092-8674(90) 90186-I (Pubitemid 20185636)
2. Chung L. W. K., Huang W.-C., Sung S.-Y., Wu D., Odero-Marah V., Nomura T., Shigemura K., Miyagi T., Seo S., Shi C., Molitierno J., Elmore J., Anderson C., Isotani S., Edlund M., Hsieh C.-L., Wang R., Shehata B., Zhau H. E., Stromal-epithelial interaction in prostate cancer progression. Clinical Genitourinary Cancer 2006 5 2 162 170 2-s2.0-33847724140 10.3816/CGC.2006.n.034
3. Niu Y.-N., Xia S.-J., Stroma-epithelium crosstalk in prostate cancer. Asian Journal of Andrology 2009 11 1 28 35 2-s2.0-69449095475 10.1038/aja.2008.39
4. Liu A. Y., Pascal L. E., Vêncio R. Z., Vêncio E. F., Stromal-epithelial interactions in early neoplasia. Cancer Biomarkers 2011 9 1-6 141 155 2-s2.0-82955193349 10.3233/CBM-2011-0174
5. Pollak M., Beamer W., Zhang J.-C., Insulin-like growth factors and prostate cancer. Cancer and Metastasis Reviews 1999 17 4 383 390 2-s2.0-0010509214 10.1023/A:1006154108619 (Pubitemid 29331788)
6. Gennigens C., Menetrier-Caux C., Droz J. P., Insulin-Like Growth Factor (IGF) family and prostate cancer. Critical Reviews in Oncology/Hematology 2006 58 2 124 145 2-s2.0-33646033772 10.1016/j.critrevonc.2005.10.003
7. Bierie B., Moses H. L., TGF- β and cancer. Cytokine and Growth Factor Reviews 2006 17 1-2 29 40 2-s2.0-30944432734 10.1016/j.cytogfr.2005.09. 006 (Pubitemid 43117514)
8. Stover D. G., Bierie B., Moses H. L., A delicate balance: TGF- β and the tumor microenvironment. Journal of Cellular Biochemistry 2007 101 4 851 861 2-s2.0-34447261691 10.1002/jcb.21149 (Pubitemid 47040867)
9. Kiskowski M. A., Jackson R. S. II, Banerjee J., Li X., Kang M., Iturregui J. M., Franco O. E., Hayward S. W., Bhowmick N. A., Role for stromal heterogeneity in prostate tumorigenesis. Cancer Research 2011 71 10 3459 3470 2-s2.0-79956116498 10.1158/0008-5472.CAN-10-2999
10. Massague J., The transforming growth factor- β family. Annual Review of Cell Biology 1990 6 597 641 2-s2.0-0025222517
11. Massagué J., How Cells read TGF-beta signals. Nature Reviews Molecular Cell Biology 2000 1 169 178
12. Derynck R., Akhurst R. J., Balmain A., TGF-beta signaling in tumor suppression and cancer progression. Nature Genetics 2001 29 117 129 (Pubitemid 32952643)
13. Massague J., Cheifetz S., Laiho M., Ralph D. A., Weis F. M. B., Zentella A., Transforming growth factor- β Cancer Surveys 1992 12 81 103 2-s2.0-0026689136
14. Derynck R., Feng X.-H., TGF- β receptor signaling. Biochimica et Biophysica Acta 1997 1333 2 F105 F150 2-s2.0-0030702810 10.1016/S0304-419X(97) 00017-6 (Pubitemid 27509074)
15. Kang J. S., Liu C., Derynck R., New regulatory mechanisms of TGF- β receptor function. Trends in Cell Biology 2009 19 8 385 394 2-s2.0-68549123472 10.1016/j.tcb.2009.05.008
16. Hong M., Wilkes M. C., Penheiter S. G., Gupta S. K., Edens M., Leof E. B., Non-Smad transforming growth factor- β signaling regulated by focal adhesion kinase binding the p85 subunit of phosphatidylinositol 3-kinase. Journal of Biological Chemistry 2011 286 20 17841 17850 2-s2.0-79955944293 10.1074/jbc.M111.233676
17. Mu Y., Gudey S. K., Landström M., Non-Smad signaling pathways. Cell and Tissue Research 2012 347 1 11 20 2-s2.0-84859443358 10.1007/s00441-011-1201- y
18. Miyazono K., Transforming growth factor- β signaling in epithelial-mesenchymal transition and progression of cancer. Proceedings of the Japan Academy B 2009 85 8 314 323 2-s2.0-74949093198 10.2183/pjab.85.314
19. Lu L., Wang J., Zhang F., Chai Y., Brand D., Wang X., Horwitz D. A., Shi W., Zheng S. G., Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. Journal of Immunology 2010 184 8 4295 4306 2-s2.0-77952777819 10.4049/jimmunol.0903418
20. Aomatsu K., Arao T., Sugioka K., Matsumoto K., Tamura D., Kudo K., Kaneda H., Tanaka K., Fujita Y., Shimomura Y., Nishio K., TGF- β induces sustained upregulation of SNAI1 and SNAI2 through smad and non-smad pathways in a human corneal epithelial cell line. Investigative Ophthalmology and Visual Science 2011 52 5 2437 2443 2-s2.0-79956033169 10.1167/iovs.10-5635
21. Lamouille S., Derynck R., Emergence of the phosphoinositide 3-kinase-akt- mammalian target of rapamycin axis in transforming growth factor- β -induced epithelial- mesenchymal transition. Cells Tissues Organs 2010 193 1-2 8 22 2-s2.0-78650510746 10.1159/000320172
22. Peehl D. M., Cohen P., Rosenfeld R. G., The insulin-like growth factor system in the prostate. World Journal of Urology 1995 13 5 306 311 2-s2.0-0029439502 10.1007/BF00185974
23. Cohen P., Peehl D. M., Baker B., Liu F., Hintz R. L., Rosenfeld R. G., Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia. Journal of Clinical Endocrinology and Metabolism 1994 79 5 1410 1415 2-s2.0-0027944342 10.1210/jc.79.5.1410 (Pubitemid 24369858)
24. Kojima S., Inahara M., Suzuki H., Ichikawa T., Furuya Y., Implications of insulin-like growth factor-I for prostate cancer therapies. International Journal of Urology 2009 16 2 161 167 2-s2.0-60349109398 10.1111/j.1442-2042. 2008.02224.x
25. Biernacka K. M., Perks C. M., Holly J. M. P., Role of the IGF axis in prostate cancer progression. Minerva Endocrinologica 2012 37 2 173 185 2-s2.0-84867293836
26. Culig Z., Hobisch A., Cronauer M. V., Hittmair A., Radmayr C., Bartsch G., Klocker H., Activation of the androgen receptor by polypeptide growth factors and cellular regulators. World Journal of Urology 1995 13 5 285 289 2-s2.0-0029442424 10.1007/BF00185971
27. Culig Z., Hobisch A., Cronauer M. V., Radmayr C., Trapman J., Hittmair A., Bartsch G., Klocker H., Androgen receptor activation in prostatic tumor cell lines by insulin- like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Research 1994 54 20 5474 5478 2-s2.0-0028113415
28. Sayeed A., Alam N., Trerotola M., Languino L. R., Insulin-like growth factor 1 stimulation of androgen receptor activity requires β 1A integrins. Journal of Cellular Physiology 2012 227 2 751 758 2-s2.0-82155181710 10.1002/jcp.22784
29. Wang Y. Z., Wong Y. C., Sex hormone-induced prostatic carcinogenesis in the Noble rat: the role of insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the development of prostate cancer. Prostate 1998 35 165 177 (Pubitemid 28211290)
30. Cunha G. R., Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer 1994 74 3 1030 1044 2-s2.0-0028037903 (Pubitemid 24231999)
31. Lee C., Sensibar J. A., Dudek S. M., Hiipakka R. A., Prostatic ductal system in rats: regional variation in morphological and functional activities. Biology of Reproduction 1990 43 6 1079 1086 2-s2.0-0025646614
32. Lee C., Nez R., Biology of the prostatic ductal system. Prostate: Clinical and Basic Aspects 1997 Boca Raton, Fla, USA CRC Press 53 71
33. Sensibar J. A., Griswold M. D., Sylvester S. R., Buttyan R., Bardin C. W., Cheng C. Y., Dudek S., Lee C., Prostatic ductal system in rats: regional variation in localization of an androgen-repressed gene product, sulfated glycoprotein-2. Endocrinology 1991 128 4 2091 2102 2-s2.0-0025833074
34. Nemeth J. A., Lee C., The prostatic ductal system in rats: regional variation in stromal organization. Prostate 1996 28 124 128 (Pubitemid 26066251)
35. Ilio K. Y., Nemeth J. A., Sensibar J. A., Lang S., Lee C., The prostatic ductal system in rats: changes in regional distribution of ECM proteins during castration-induced regression. Prostate 2000 43 3 10 (Pubitemid 30164238)
36. Zhou W., Park I., Pins M., Kozlowski J. M., Jovanovic B., Zhang J., Lee C., Ilio K., Dual regulation of proliferation and growth arrest in prostatic stromal cells by transforming growth factor- β 1. Endocrinology 2003 144 10 4280 4284 2-s2.0-0141673551 10.1210/en.2003-0554 (Pubitemid 37204825)
37. Yu N., Kozlowski J. M., Park I. I., Chen L., Zhang Q., Xu D., Doll J. A., Crawford S. E., Brendler C. B., Lee C., Overexpression of transforming growth factor β 1 in malignant prostate cells is partly caused by a runaway of TGF- β 1 Auto-induction mediated through a defective recruitment of protein phosphatase 2A by TGF- β type i receptor. Urology 2010 76 6 1519.e8 1519.e13 2-s2.0-78649903609 10.1016/j.urology.2010.03.061
38. Hirasawa Y., Sakai T., Ito M., Yoshimura H., Feng Y., Nagamatsu T., Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway. European Journal of Pharmacology 2011 672 1-3 159 168 2-s2.0-81255160771 10.1016/j.ejphar.2011.09.185
39. Zhang Q., Chen L., Helfand B. T., Transforming Growth Factor-â-induced DNA methyltransferase contributes to aggressive prostate cancer phenotypes and predicts biochemical recurrence after radical prostatectomy. PloS ONE 2011 6 e25168
40. Gu L., Zhu Y.-J., Yang X., Guo Z.-J., Xu W.-B., Tian X.-L., Effect of TGF- β /Smad signaling pathway on lung myofibroblast differentiation. Acta Pharmacologica Sinica 2007 28 3 382 391 2-s2.0-33847210725 10.1111/j.1745-7254. 2007.00468.x
41. Caraci F., Gili E., Calafiore M., Failla M., La Rosa C., Crimi N., Sortino M. A., Nicoletti F., Copani A., Vancheri C., TGF- β 1 targets the GSK-3 β / β -catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacological Research 2008 57 4 274 282 2-s2.0-43049175154 10.1016/j.phrs.2008.02.001
42. Shaw A., Gipp J., Bushman W., The Sonic Hedgehog pathway stimulates prostate tumor growth by paracrine signaling and recapitulates embryonic gene expression in tumor myofibroblasts. Oncogene 2009 28 50 4480 4490 2-s2.0-72449149112 10.1038/onc.2009.294
43. Schauer I. G., Rowley D. R., The functional role of reactive stroma in benign prostatic hyperplasia. Differentiation 2011 82 4-5 200 210 2-s2.0-80051787167 10.1016/j.diff.2011.05.007
44. Franco O. E., Jiang M., Strand D. W., Peacock J., Fernandez S., Jackson R. S. II, Revelo M. P., Bhowmick N. A., Hayward S. W., Altered TGF- β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. Cancer Research 2011 71 4 1272 1281 2-s2.0-79951842547 10.1158/0008-5472.CAN-10-3142
45. de Wever O., Demetter P., Mareel M., Bracke M., Stromal myofibroblasts are drivers of invasive cancer growth. International Journal of Cancer 2008 123 10 2229 2238 2-s2.0-53449094862 10.1002/ijc.23925
46. Chung L. W. K., The role of stromal-epithelial interaction in normal and malignant growth. Cancer Surveys 1995 23 33 42 2-s2.0-0029025319
47. Rowley D. R., What might a stromal response mean to prostate cancer progression? Cancer and Metastasis Reviews 1999 17 4 411 419 2-s2.0-0032809359 10.1023/A:1006129420005 (Pubitemid 29331791)
48. Bhowmick N. A., Chytil A., Plieth D., Gorska A. E., Dumont N., Shappell S., Washington M. K., Neilson E. G., Moses H. L., TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004 303 5659 848 851 2-s2.0-0842288323 10.1126/science.1090922 (Pubitemid 38174665)
49. Ao M., Franco O. E., Park D., Raman D., Williams K., Hayward S. W., Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Research 2007 67 9 4244 4253 2-s2.0-34249295225 10.1158/0008-5472.CAN-06-3946 (Pubitemid 46815071)
50. Kawada M., Inoue H., Arakawa M., Ikeda D., Transforming growth factor- β 1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I. Anticancer Research 2008 28 2 721 730 2-s2.0-42549130882 (Pubitemid 351578914)
51. Kawada M., Inoue H., Usami I., Ikeda D., Phthoxazolin A inhibits prostate cancer growth by modulating tumor-stromal cell interactions. Cancer Science 2009 100 1 150 157 2-s2.0-58149307940 10.1111/j.1349-7006.2008.00996.x
52. Dooley S., Delvoux B., Lahme B., Mangasser-Stephan K., Gressner A. M., Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology 2000 31 5 1094 1106 2-s2.0-0034094837 (Pubitemid 30233234)
53. Ghahary A., Shen Q., Shen Y. I., Scott P. G., Tredget E. E., Induction of transforming growth factor b1 by insulin-like growth factor-1 in dermal fibroblasts. Journal of Cellular Physiology 1998 174 301 309 (Pubitemid 28068707)
54. Tripathi M., Billet S., Bhowmick N. A., Understanding the role of stromal fibroblasts in cancer progression. Cell Adhesion and Migration 2012 6 3 231 235 2-s2.0-84864955960 10.4161/cam.20419
55. Verrecchia F., Chu M.-L., Mauviel A., Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. Journal of Biological Chemistry 2001 276 20 17058 17062 2-s2.0-0035907240 10.1074/jbc.M100754200
56. Hodkinson P. S., Mackinnon A. C., Sethi T., Extracellular matrix regulation of drug resistance in small-cell lung cancer. International Journal of Radiation Biology 2007 83 11-12 733 741 2-s2.0-36849038378 10.1080/09553000701570204 (Pubitemid 350219111)
57. Li X., Sterling J. A., Fan K.-H., Vessella R. L., Shyr Y., Hayward S. W., Matrisian L. M., Bhowmick N. A., Loss of TGF- β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/ osteolytic bone lesions. Molecular Cancer Research 2012 10 4 494 503 2-s2.0-84859827014 10.1158/1541-7786.MCR-11-0506
58. Sakko A. J., Ricciardelli C., Mayne K., Suwiwat S., LeBaron R. G., Marshall V. R., Tilley W. D., Horsfall D. J., Modulation of prostate cancer cell attachment to matrix by versican. Cancer Research 2003 63 16 4786 4791 2-s2.0-0041940130 (Pubitemid 37022606)
59. Zhang Q., Yang X. J., Kundu S. D., Pins M., Javonovic B., Meyer R., Kim S.-J., Greenberg N. M., Kuzel T., Meagher R., Guo Y., Lee C., Blockade of transforming growth factor- β signaling in tumor-reactive CD8+ T cells activates the antitumor immune response cycle. Molecular Cancer Therapeutics 2006 5 7 1733 1743 2-s2.0-33748293112 10.1158/1535-7163.MCT-06-0109 (Pubitemid 44323241)
60. Fukumura D., Xavier R., Sugiura T., Chen Y., Park E.-C., Lu N., Selig M., Nielsen G., Taksir T., Jain R. K., Seed B., Tumor induction of VEGF promoter activity in stromal cells. Cell 1998 94 6 715 725 2-s2.0-0032544686 10.1016/S0092-8674(00)81731-6 (Pubitemid 28436004)
61. Jia Z., Wang Y., Sawyers A., Yao H., Rahmatpanah F., Xia O.-Q., Xu Q., Pio R., Turan T., Koziol J. A., Goodison S., Carpenter P., Wang-Rodriguez J., Simoneau A., Meyskens F., Sutton M., Lernhardt W., Beach T., Monforte J., McClelland M., Mercola D., Diagnosis of prostate cancer using differentially expressed genes in stroma. Cancer Research 2011 71 7 2476 2487 2-s2.0-79953309070 10.1158/0008-5472.CAN-10-2585
62. Mohler J. L., Chen Y., Hamil K., Hall S. H., Cidlowski J. A., Wilson E. M., French F. S., Sar M., Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma. Clinical Cancer Research 1996 2 5 889 895 2-s2.0-0029996555 (Pubitemid 26168942)
63. Le H., Arnold J. T., McFann K. K., Blackman M. R., DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells. American Journal of Physiology. Endocrinology and Metabolism 2006 290 5 E952 E960 2-s2.0-33646435242 10.1152/ajpendo.00451.2005
64. Chipuk J. E., Cornelius S. C., Pultz N. J., Jorgensen J. S., Bonham M. J., Kim S.-J., Danielpour D., The androgen receptor represses transforming growth factor- β signaling through interaction with Smad3. Journal of Biological Chemistry 2002 277 2 1240 1248 2-s2.0-0037059735 10.1074/jbc. M108855200 (Pubitemid 34968875)
65. Qi W., Gao S., Chu J., Zhou L., Wang Z., Negative androgen-response elements mediate androgen-dependent transcriptional inhibition of TGF- β 1 and CDK2 promoters in the prostate gland. Journal of Andrology 2012 33 1 27 36 2-s2.0-84863011667 10.2164/jandrol.110.011999
66. Hayes S. A., Zarnegar M., Sharma M., Yang F., Peehl D. M., Ten Dijke P., Sun Z., SMAD3 represses androgen receptor-mediated transcription. Cancer Research 2001 61 5 2112 2118 2-s2.0-0035266183 (Pubitemid 32692035)
67. Kang H.-Y., Lin H.-K., Hu Y.-C., Yeh S., Huang K.-E., Chang C., From transforming growth factor- β signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells. Proceedings of the National Academy of Sciences of the United States of America 2001 98 6 3018 3023 2-s2.0-0035853055 10.1073/pnas.061305498 (Pubitemid 32220792)
68. Zhu M.-L., Partin J. V., Bruckheimer E. M., Strup S. E., Kyprianou N., TGF- β signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Prostate 2008 68 3 287 295 2-s2.0-39449103998 10.1002/pros.20698 (Pubitemid 351273058)
69. Kang H.-Y., Huang K.-E., Chang S. Y., Ma W.-L., Lin W.-J., Chang C., Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. Journal of Biological Chemistry 2002 277 46 43749 43756 2-s2.0-0037113990 10.1074/jbc.M205603200 (Pubitemid 36157793)
70. Park I. I., Zhang Q., Liu V., Kozlowski J. M., Zhang J., Lee C., 17 β -Estradiol at low concentrations acts through distinct pathways in normal versus benign prostatic hyperplasia-derived prostate stromal cells. Endocrinology 2009 150 10 4594 4605 2-s2.0-70349321290 10.1210/en.2008-1591
71. Morani A., Warner M., Gustafsson J.-Å., Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues. Journal of Internal Medicine 2008 264 2 128 142 2-s2.0-46949089089 10.1111/j.1365-2796.2008.01976.x (Pubitemid 351962577)
72. Pandini G., Genua M., Frasca F., Squatrito S., Vigneri R., Belfiore A., 17 β -estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells. Cancer Research 2007 67 18 8932 8941 2-s2.0-34548768315 10.1158/0008-5472.CAN-06-4814 (Pubitemid 47437471)
73. Yu L., Wang C.-Y., Shi J., Miao L., Du X., Mayer D., Zhang J., Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells. Endocrinology 2011 152 3 773 781 2-s2.0-79951867608 10.1210/en.2010-1239
74. Slavin S., Yeh C. R., Da J., Estrogen receptor a in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3. Carcinogenesis 2014
75. Dhasarathy A., Phadke D., Mav D., Shah R. R., Wade P. A., The transcription factors snail and slug activate the transforming growth factor-beta signaling pathway in breast cancer. PLoS ONE 2011 6 10 2-s2.0-80054784515 10.1371/journal.pone.0026514 e26514
76. Cavalieri E. L., Rogan E. G., A unified mechanism in the initiation of cancer. Cellular and Molecular Life Sciences 2002 59 4 665 681
77. Cavalieri E. L., Rogan E. G., Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer. Journal of Steroid Biochemistry and Molecular Biology 2011 125 3-5 169 180 2-s2.0-79957791696 10.1016/j.jsbmb.2011.03.008
78. Abd Elmageed Z. Y., Moroz K., Srivastav S. K., High circulating estrogens and selective expression of ER β in prostate tumors of Americans: implications for racial disparity of prostate cancer. Carcinogenesis 2013 34 9 2017 2023
79. Noble R. L., Production of Nb rat carcinoma of the dorsal prostate and response of estrogen-dependent transplants to sex hormones and tamoxifen. Cancer Research 1980 40 10 3547 3550 2-s2.0-0018932456 (Pubitemid 10003747)
80. Ho S.-M., Roy D., Sex hormone-induced nuclear DNA damage and lipid peroxidation in the dorsolaterel prostates of Noble rats. Cancer Letters 1994 84 2 155 162 2-s2.0-0028109167 10.1016/0304-3835(94)90370-0 (Pubitemid 24280147)
81. Taylor R. A., Toivanen R., Frydenberg M., Pedersen J., Harewood L., Collins A. T., Maitland N. J., Risbridger G. P., Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status. Stem Cells 2012 30 6 1087 1096 2-s2.0-84861881705 10.1002/stem.1094
82. Cunha G. R., Hayward S. W., Wang Y. Z., Ricke W. A., Role of the stromal microenvironment in carcinogenesis of the prostate. International Journal of Cancer 2003 107 1 1 10 2-s2.0-0042415425 10.1002/ijc.11335 (Pubitemid 37100079)
83. Cavalieri E. L., Devanesan P., Bosland M. C., Badawi A. F., Rogan E. G., Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer. Carcinogenesis 2002 23 2 329 333 2-s2.0-0036121516 (Pubitemid 34224011)
84. Cohen P., Peehl D. M., Craves H. C. B., Rosenfeld R. C., Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. Journal of Endocrinology 1994 142 3 407 415 2-s2.0-0028048974 (Pubitemid 24285445)
85. Lonning S., Mannick J., McPherson J. M., Antibody targeting of TGF- β in cancer patients. Current Pharmaceutical Biotechnology 2011 12 12 2176 2189 2-s2.0-84855222588 10.2174/138920111798808392
86. Sung S.-Y., Chung L. W. K., Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting. Differentiation 2002 70 9-10 506 521 2-s2.0-0036992758 10.1046/j.1432-0436.2002.700905.x (Pubitemid 36194316)
87. Arnaldez F. I., Helman L. J., Targeting the insulin growth factor receptor 1. Hematology/Oncology Clinics of North America 2012 26 3 527 542 2-s2.0-84859979292 10.1016/j.hoc.2012.01.004